These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 16754908)
1. The perverted irony of Health Canada's Special Access Programme. Christie TK; Montaner JS CMAJ; 2006 Jun; 174(12):1746. PubMed ID: 16754908 [No Abstract] [Full Text] [Related]
2. Regulators deny access to experimental hepatitis C drug. Hillson G Can HIV AIDS Policy Law Rev; 2002 Dec; 7(2-3):31-2. PubMed ID: 14719494 [TBL] [Abstract][Full Text] [Related]
3. Justice and access to therapies for AIDS. Eckenwiler L AIDS Public Policy J; 1999; 14(1):20-5. PubMed ID: 10915283 [No Abstract] [Full Text] [Related]
4. Amendments to the Canadian Patent Act to address drug access: is help on the way? Penner MD; Narayanan P Food Drug Law J; 2005; 60(3):459-70. PubMed ID: 16304751 [No Abstract] [Full Text] [Related]
5. International intellectual property, access to health care, and human rights: South Africa v. United States. Nagan WP Fla J Int Law; 2002; 14(2):155-91. PubMed ID: 16526137 [No Abstract] [Full Text] [Related]
6. Is it time to rethink the expanded-access programs for HIV infection? Amorosa V; Tebas P J Infect Dis; 2007 Oct; 196(7):974-7. PubMed ID: 17763316 [TBL] [Abstract][Full Text] [Related]
7. HIV/AIDS: Latin America & Caribbean. Peru: universal access: more goal than reality. Cohen J Science; 2006 Jul; 313(5786):489. PubMed ID: 16873658 [No Abstract] [Full Text] [Related]
8. Virodene down but not out. Jones JS S Afr Med J; 1999 Feb; 89(2):116, 118. PubMed ID: 10191855 [No Abstract] [Full Text] [Related]
9. South African firm gets US approval for AIDS drugs. AIDS Read; 2005 Apr; 15(4):150. PubMed ID: 15846847 [No Abstract] [Full Text] [Related]
10. VSO launches campaign to increase access to AIDS drugs. Roach JO BMJ; 2000 Oct; 321(7268):1038. PubMed ID: 11053159 [No Abstract] [Full Text] [Related]
11. FDA grants tentative approval for 75th generic antiretroviral drug. Lang L Gastroenterology; 2009 Jan; 136(1):5. PubMed ID: 19059409 [No Abstract] [Full Text] [Related]
12. Several AIDS drugs tentatively approved. FDA Consum; 2005; 39(5):3. PubMed ID: 16421982 [No Abstract] [Full Text] [Related]
13. Canada falters on promise of AIDS drugs for Africa. Silversides A CMAJ; 2006 Sep; 175(7):726. PubMed ID: 17001042 [No Abstract] [Full Text] [Related]
14. MPs call for removal of Health Canada's breast-implant panel members. Eggertson L CMAJ; 2005 Nov; 173(10):1144. PubMed ID: 16275959 [No Abstract] [Full Text] [Related]
16. Uncertain future for early access? Huff B GMHC Treat Issues; 2006; 20(1-3):1-3. PubMed ID: 16906670 [No Abstract] [Full Text] [Related]
17. Moral regulation and the presumption of guilt in Health Canada's medical cannabis policy and practice. Lucas P Int J Drug Policy; 2009 Jul; 20(4):296-303. PubMed ID: 19124233 [TBL] [Abstract][Full Text] [Related]
18. 124 drugs currently in development. AIDS Patient Care STDS; 1998 Feb; 12(2):149. PubMed ID: 11361916 [No Abstract] [Full Text] [Related]
19. WHO removes 3 more AIDS drugs from approved list. Bull World Health Organ; 2004 Sep; 82(9):718. PubMed ID: 15628217 [No Abstract] [Full Text] [Related]
20. HIV drug development: the next 25 years. Flexner C Nat Rev Drug Discov; 2007 Dec; 6(12):959-66. PubMed ID: 17932493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]